GlassScriptPhysician profile
Christopher T Scholes
NPI 1760491542
$3,268.31
in general payments reported to CMS, 2019-2025
20 companies · $520 in 2025
The $520 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $516 · 2020: $275 · 2021: $648 · 2022: $662 · 2023: $286 · 2024: $360 · 2025: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,068 · Education: $98.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,068.10 |
| Education | $98.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,056.77 | 2019-2025 | Skyrizi |
| Janssen Biotech, INC. | $690.79 | 2019-2025 | Tremfya, Stelara, Simponi Aria |
| Novartis Pharmaceuticals Corporation | $271.69 | 2022-2025 | |
| Ucb, INC. | $219.40 | 2019-2025 | Bimzelx, Cimzia |
| Regeneron Healthcare Solutions, INC. | $164.07 | 2019-2024 | Dupixent |
| Lilly USA, LLC | $149.87 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Sun Pharmaceutical Industries INC. | $148.02 | 2019-2022 | |
| Pfizer INC. | $118.60 | 2019-2022 | |
| Organon LLC | $93.50 | 2023-2025 | Vtama, Hadlima |
| Incyte Corporation | $59.52 | 2022 | |
| Genzyme Corporation | $59.10 | 2021-2023 | |
| Leo Pharma INC. | $46.15 | 2022-2023 | Adbry |
| E.R. Squibb & Sons, L.L.C. | $35.05 | 2023-2024 | Sotyktu |
| Galderma Laboratories, L.P. | $29.97 | 2021 | |
| Amgen INC. | $29.24 | 2024 | Otezla |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $29.01 | 2023-2024 | Vtama |
| Sensus Healthcare, INC. | $19.72 | 2024 | |
| Organogenesis INC. | $19.65 | 2023 | Puraply |
| Mimedx Group, INC. | $15.52 | 2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $12.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Scholes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.